Evidence map›Paper›PMID 30112187›Full record

ArticleFuture science OA2018

RAB40C regulates RACK1 stability via the ubiquitin-proteasome system.

Jon P Day, Ellanor Whiteley, Michael Freeley, Aideen Long, Beatrice Malacrida, Patrick Kiely, George S Baillie

Open access · goldAbstract read
In one paragraph

Article in Future science OA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. RAB40C regulates SNX9 stabilityCentral-European journal of immunology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Interactions of Lipid Droplets with the Intracellular Transport Machinery.International journal of molecular sciences · 2021
    Review
  13. PHB2 promotes tumorigenesisTheranostics · 2021
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jon P DayInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Ellanor WhiteleyInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Michael FreeleyDepartment of Clinical Medicine, Institute of Molecular Medicine, Trinity College, Dublin, D08 W9RT, Ireland.
Aideen LongDepartment of Clinical Medicine, Institute of Molecular Medicine, Trinity College, Dublin, D08 W9RT, Ireland.
Beatrice MalacridaMaterials & Surface Science Institute & Health Research Institute, University of Limerick, Limerick, Ireland.
Patrick KielyMaterials & Surface Science Institute & Health Research Institute, University of Limerick, Limerick, Ireland.
George S BaillieInstitute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
University of Glasgow · GBTrinity College Dublin · IEUniversity of Limerick · IE

Funding

Medical Research Council MR/J007412/1Medical Research Council MR/M013944/1
6 · The paper itself

Abstract

aimRACK1 is a multifunctional scaffolding protein that is expressed in many cellular compartments, orchestrating a number of signaling processes. RACK1 acts as a signaling hub to localize active enzymes to discrete locations; therefore tight control of RACK1 is vital to cellular homeostasis. Our aim was to identify the mechanisms responsible for RACK1 turnover and show that degradation is directed by the ubiquitin proteasome system.

resultsUsing siRNA screening, we identified RAB40C as the ubiquitin E3 ligase responsible for ubiquitination of RACK1, and that the action of RAB40C in controlling RACK1 levels is crucial to both cancer cell growth and migration of T cells.

conclusionOur data suggest that manipulation of RACK1 levels in this way may provide a novel strategy to explore RACK1 function.

Indexed as

RAB40CRACK1ubiquitin–proteasome system

Identifiers

PMID30112187
PMCPMC6088270
OpenAlexW2804129860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.